OMIC — Singular Genomics Systems Share News
0.000.00%
Last trade - 00:00- $50.26m
- -$53.51m
- $2.91m
Singular Genomics Systems Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Singular Genomics Systems Says On July 17, Co Got Deficiency Letter From Nasdaq
Singular Genomics Systems Inc reports results for the quarter ended in March - Earnings Summary
Brief: Singular Genomics Systems Q1 net loss USD 23.633 million
Brief: Singular Genomics Reports First Quarter 2023 Financial Results
Singular Genomics Systems Inc expected to post a loss of 35 cents a share - Earnings Preview
Singular Genomics Systems Inc reports results for the quarter ended in December - Earnings Summary
Brief: Singular Genomics Reports Recent Highlights And Q4 And Full Year 2022 Financial Results
Brief: Singular Genomics Systems Q4 net loss USD -21.1 million
Singular Genomics Systems Inc expected to post a loss of 43 cents a share - Earnings Preview
Brief: Singular Genomics Launches Max Read™ Kits For Single Cell Sequencing On The G4 At Agbt
Brief: Singular Genomics Reports Instrument Shipments And Preliminary Unaudited Q4 2022 Revenue
Singular Genomics Systems Inc reports results for the quarter ended in September - Earnings Summary
Brief: Singular Genomics Systems Inc Reports Q3 Loss Per Share Of $0.33
Singular Genomics Systems Inc expected to post a loss of 41 cents a share - Earnings Preview
Singular Genomics hits record low on weak sequencing system shipments
Singular Genomics Systems Inc reports results for the quarter ended in June - Earnings Summary
Brief: Singular Genomics Systems Reports Net Loss For Q2 2022 Was $24.0 Mln
Brief: Singular Genomics Systems Files For Mixed Shelf Of Up To $250 Million